Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

49 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Grifols announces positive topline phase 3 fibrinogen clinical trial results
AQ
GRIFOLS : Grifols accelerates its governance improvements post the short-seller’s allegations
Alphavalue
Grifols Announces Executive Changes
CI
Grifols announces changes in governance to separate management from ownership as part of planned strategy
AQ
Spain's Grifols hires new CEO weeks after damaging short-seller report
RE
Grifols receives FDA approval for expanded immunoglobulin purification and filling capacity at its North Carolina site
AQ
Transcript : Grifols, S.A., Q3 2023 Earnings Call, Nov 02, 2023
Grifols S A : appoints Miguel Louzan Chief Digital Information Officer
PU
Grifols names Dr Jorg Schuttrumpf Chief Scientific Innovation Officer
AQ
Transcript : Grifols, S.A., Q2 2023 Earnings Call, Jul 27, 2023
Grifols highlights the acceleration of its operating performance and reiterates its strong commitment to debt reduction
AQ
Grifols S A : highlights the acceleration of its operating performance and reiterates its strong commitment to debt reduction
PU
Grifols S A : June 16 2023Grifols highlights the acceleration of its operating performance and reiterates its strong commitment to debt reduction
PU
Grifols welcomes Egypt's ambassador to Spain at its plasma processing plant in Parets del Valles
AQ
Grifols S A : First Quarter 2023 – Conference call transcript
PU
GRIFOLS : Upbeat Q1 a much-needed boost to investor confidence
Alphavalue
Transcript : Grifols, S.A., Q1 2023 Earnings Call, May 09, 2023
Grifols S A : delivers strong first quarter financials with 23% revenue growth and an Adjusted EBITDA margin above guidance of 21%
PU
Grifols S A : May 9 2023Grifols delivers strong first quarter financials with 23% revenue growth and an Adjusted EBITDA margin above guidance of 21%
PU
Grifols S A : First Quarter 2023 Results earnings release – Press Release
PU
Grifols S A : First Quarter 2023 Results earnings release – Presentation
PU
Grifols S A : realigns management structure to accelerate company performance and simplify its corporate governance
PU
Grifols S A : May 8 2023Grifols realigns management structure to accelerate company performance and simplify its corporate governance
PU
Grifols enters into global collaboration and licensing agreement with Selagine to develop immunoglobulin eye drops to treat dry eye disease
AQ
Grifols S A : Full year 2022 – Conference call transcript
PU
Transcript : Grifols, S.A., 2022 Earnings Call, Feb 28, 2023
Grifols S A : delivers strong 2022 performance and is positioned for sustainable future growth
PU
Grifols S A : February 28 2023Grifols delivers strong 2022 performance and is positioned for sustainable future growth
PU
Grifols S A : Full year 2022 earnings release – Press Release
PU
Grifols S A : First half 2022 earnings release - Press release
PU
Grifols S A : Third Quarter 2022 Business update – Conference call transcript
PU
Transcript : Grifols, S.A., Q3 2022 Earnings Call, Nov 08, 2022
Grifols S A : ’ Biopharma delivers robust 34% operational growth in Q3, driving revenues to EUR 4,351m in the first nine months of 2022
PU
Grifols S A : November 8 2022Grifols’ Biopharma delivers robust 34% operational growth in Q3, driving revenues to EUR 4,351m in the first nine months of 2022
PU
Grifols S A : Third quarter earnings release
PU
Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson
PR
Grifols : Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030
PR
Grifols S A : delivers first manufactured batches of its anti-SARS-CoV-2 hyperimmune globulin for clinical trials
PR
Grifols : July 28, 2020Grifols delivers first manufactured batches of its anti-SARS-CoV-2 hyperimmune globulin for clinical trials
PU
Grifols : May 5, 2020 Grifols completes development of very high sensitivity molecular test to detect SARS-CoV-2 virus Read more
PU
Grifols : completes development of very high sensitivity molecular test to detect SARS-CoV-2 virus
AQ
Grifols : S.A. annual accounts, auditor's report and directors' report for the financial year 2019
PU
Grifols : and Mondragon sign technology collaboration agreement
PU
Grifols : selected to build its first intravenous solutions manufacturing line in Africa
PU
Grifols : donations of blood clotting factor helping people with hemophilia globally
PR
Grifols : donates over 25 million international units of blood clotting factor in 2017
PR
Grifols, S.A. Announces Management Changes, Effective January 1, 2017
CI
Grifols : makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company Download (22.3 Kb)
PU
Grifols : makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company
PU
No results for this search
  1. Stock Market
  2. Advanced search
  3. Victor Grifols Deu
  4. News